Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.285 | 16.6666666667 | 1.71 | 2.0299 | 1.58 | 1512256 | 1.72144834 | CS |
| 4 | -0.545 | -21.4566929134 | 2.54 | 3.08 | 1.58 | 2331973 | 1.97075644 | CS |
| 12 | 0.285 | 16.6666666667 | 1.71 | 3.08 | 1.2905 | 2481224 | 2.23351112 | CS |
| 26 | -2.215 | -52.6128266033 | 4.21 | 4.59 | 1.2905 | 1502664 | 2.38832789 | CS |
| 52 | -2.825 | -58.6099585062 | 4.82 | 13.07 | 1.2905 | 1154959 | 4.12041944 | CS |
| 156 | -9.995 | -83.3611342786 | 11.99 | 43.69 | 1.2905 | 868261 | 11.38621383 | CS |
| 260 | -18.005 | -90.025 | 20 | 43.69 | 1.2905 | 660822 | 11.32089187 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
